Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
This study is currently recruiting participants.
Verified October 2012
by ICORG- All Ireland Cooperative Oncology Research Group
Study NCT01566747 Information provided by ICORG- All Ireland Cooperative Oncology Research Group
First Received on March 8, 2012. Last Updated on October 22, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Renal Cell Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Renal Cell
More general conditions related to this trial
Adenocarcinoma
Kidney Diseases
Kidney Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
Pazopanib
Sponsors listed in this trial
ICORG- All Ireland Cooperative Oncology Research Group
GlaxoSmithKline
Back to top of Main Content